drugset / Trial / NCT01020877

Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects

NCT01020877

Phase 1 Completed 38 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-label

Summary

The primary object of this study was to evaluate the relative bioavailability of the test formulation of metronidazole vaginal gel with the already marketed reference formulation MetroGel-Vaginal Gel® in healthy adult female subjects.

Timeline

Start
2001-11
Primary completion
2001-11
Completion
2002-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metronidazole Small molecule 0.75 % Other

Indications

No indication recorded.